Back to search

Switzerland· 69777003

Teicoplanin-Evultis 400 mg, Polvere per soluzione iniettabile/per infusione o soluzione orale

A teicoplanin product containing teicoplaninum, registered in Switzerland by Evultis SA and dispensed under Swissmedic category A. The same ATC class is registered in 15 of our 19 countries.

Cat A (Swissmedic)ATC J01XA02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedTeicoplanin-Evultis 400 mg, Polvere p…ATCJ01XA02REGISTER NO.69777003PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Teicoplanin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01XA02 (teicoplanin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Teicoplanin · ATC J01XA02

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
teicoplaninum
Manufacturer
Evultis SA
Country
Switzerland (CH)
ATC code
J01XA02
ATC class
Teicoplanin
Defined daily dose
0.4 g, P
Swissmedic category
A
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Teicoplanin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All teicoplanin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Teicoplanin Accord, Teicoplanin Altan
  • Belgium · Targocid, Teicoplanin Bradex
  • Bulgaria · Планитек, Планицид
  • Cyprus · Talinac, Teicoplanin Aptapharma
  • Czechia · Targocid, Teicoplanin Aptapharma
  • Germany · Teicoplanin Altan, Teicoplanin Centurion
  • Denmark · Targocid, Teicoplanin Demo S.A.
  • Spain · Targocid, Teicoplanina Accord
  • Finland · Targocid, Teicoplanin Demo S.A.
  • France · Targocid, Teicoplanine Altan
  • United Kingdom (Northern Ireland) · Targocid, Teicoplanin
  • Greece · Talinac, Targocid
  • Croatia · Targocid, Teikoplanin Aptapharma
  • Hungary · Targocid, Teicoplanin Anfarm
  • Ireland · Targocid, Teicoplanin Hikma
  • Italy · Planicid, Targosid
  • Luxembourg · Targocid
  • Malta · Targocid, Teicoplanin Anfarm
  • Netherlands · Targocid, Teicoplanin Sun
  • Norway · Teicoplanin Demo S.A.
  • Poland · Targocid, Teicoplanin Altan
  • Portugal · Teicoplanina Accord, Teicoplanina Altan
  • Romania · Targocid, Teicoplanină Aptapharma
  • Sweden · Targocid, Teicoplanin Bradex
  • Slovenia · Targocid, Teikoplanin Aptapharma
  • Slovakia · Targocid, Teicoplanin Aptapharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cfc3a5e8-bc83-46dc-b367-47a76e708fab
GET /v1/drugs/cfc3a5e8-bc83-46dc-b367-47a76e708fab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about teicoplanin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.